Overview

Update
Total Equity Funding
$90M in 3 Rounds from 7 Investors
Most Recent Funding
$55M Series C on September 26, 2016
Headquarters:
Hayward, California
Description:
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Founders:
,
Categories:
Health Care, Biotechnology, Medical
Website:
http://micurx.com

Company Details

Update

MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available in China. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.

Funding Rounds (3) - $90M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2016$55M / Series C4
Aug, 2013$25M / Series B3
Jun, 2007$10M / Series A1

Current Team (2)

Update
  • Founder, Chief Scientific Officer and Executive Vice President
  • Founder, Chief Executive Officer and President

Offices/Locations (1)

Update
  • Headquarters

    3916 Trust Way

    Hayward, California 94545

    United States

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos